MiniMax’s M2.5 is the latest proof that frontier-ish agent models are rapidly commoditizing on token price (≈$0.15/$1.20 per 1M input/output tokens; “Lightning” ≈$0.30/$2.40) while achieving competitive agent benchmarks. But, as we all know, cheap comes at a price; and governance is the bill that will come due.
Most health systems are treating the documentation burden as a staffing and tooling problem, but the evidence says that the constraint is more basic. Clinicians are burning cognitive capacity on navigation, fragmentation, and poorly organized data, not on care.
Most organizations are trying to jump from “chat assistant” to “autonomous agent,” but the adoption constraint is security invariants, not model capability. Prompt injection turns routine web/email content into control flow, and trying to “train/detect your way out” remains a brittle option.
NSA, CISA, and international partners have issued clear guidance on integrating AI into operational technology, and it lands as a governance signal, not a green light for speed. The practical takeaway for CIOs is direct: treat OT-facing AI as regulated infrastructure from day one, with mandatory oversight, testing gates, and human control built in before scale.
Most enterprises are piloting agentic AI at the edges of workflows while simultaneously committing to platform-wide deployments they cannot safely govern. Only 11% have agents in true production; over 40% of current projects are on track to be canceled for cost, governance, or risk reasons within two years.
Blue/green deployments are a safety net for SMEs, providing near-zero downtime and seamless rollbacks, but they can quickly inflate costs if left unmanaged. A smart, on-demand approach to green environments keeps your systems resilient and your ledger happy.
